Also found in: Medical, Wikipedia.
Related to pramlintide: Colesevelam, Exenatide, Symlin


An injectable drug that is a synthetic analog of the hormone amylin, used in the form of its acetate salt to treat type 1 and type 2 diabetes.

[pram-, of unknown origin + -lintide, amylin derivative or mimic suffix ((amy)lin + (pep)tide).]


n pramlintida
References in periodicals archive ?
The medication, pramlintide (Symlin), slows the absorption of food and may cause some weight loss, according to the ADA.
Medications that produce a moderate/marked reduction of the PPG are rapid- and short-acting GLP-1RAs, prandial insulins, and pramlintide.
Keywords: Alpha-glucosidase inhibitors, DPP4 inhibitors, GLP1 receptor agonists, Metformin, Pioglitazone, Pramlintide, SGLT2 inhibitors.
IAPP hyposecretion is well-established in T1DM and insulin-requiring T2DM [43,45]: A synthetic IAPP, pramlintide [28-30] (pro-hIAPP) has been used for treating both T1DM and insulin-requiring T2DM together with insulin replacement for a better glycemic control [46-49].
The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis.
Liraglutide (Victoza[R]) Dulaglutide (Truliclty[R]) Amlyn analogue Pramlintide Slows digestion which (Symlin[R]) slows release of glucose into bloodstream.
Other, less commonly used drugs for T2DM include pramlintide (Symlin[R], not licensed in Europe for T2DM), colesevelam (Welchol[R]), and bromocriptine (Parlodel[R]).
Pramlintide Leptin is a hormone produced by adipocytes and early studies linked leptin deficiency in mice to massive obesity.
In obese patients with [type 2 diabetes] requiring insulin therapy, we suggest adding at least one of the following: metformin, pramlintide (Symlin), or GLP-1 (glucagonlike peptide-1 receptor) agonists to mitigate associated weight gain due to insulin," they noted.
16) A synthetic form of amylin, Pramlintide is used along with insulin and glucagon to also maintain blood glucose levels.
Washington, March 25 ( ANI ): While conducting an experimental model, researchers found that pramlintide, a diabetic drug, helps in reducing amyloid-beta peptides, a major element of Alzheimer's disease (AD) in the brain.
Pramlintide (Symlin) also is an injectable drug for treatment of type 1 and type 2 diabetes.